With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral sclerosis – a debilitating and fatal neurological disease for which there is no cure. The novel treatment slowed disease progression, improved muscle function and extended lifespan in mice with an aggressive form of ALS.
“ALS unfortunately has few treatment options. This is an important first step in showing that this new form of gene editing could be used to potentially treat the disease,” said bioengineering professor Thomas Gaj, who co-led the study with bioengineering professor Pablo Perez-Pinera.
The method relied on an emerging gene-editing technology known as CRISPR base editors.
Traditional CRISPR gene-editing technologies cut both strands of a DNA molecule, which can introduce a variety of errors in the DNA sequence, limiting its efficiency and potentially leading to a number of unintended mutations in the genome. The Illinois group instead used base editing “to change one letter of the DNA sequence to another without cutting through both DNA strands,” Perez-Pinera said.
“Base editors are too large to be delivered into cells with one of the most promising and successful gene therapy vectors, known as adeno-associated virus,” Gaj said. However, in 2019, Perez-Pinera’s group developed a method of splitting the base editor proteins into halves that can be delivered by two separate AAV particles. Once inside the cell, the halves reassemble into the full-length base editor protein.
By combining the power of AAV gene delivery and split-base editors, Gaj and Perez-Pinera targeted and permanently disabled a mutant SOD1 gene, which is responsible for roughly 20% of inherited forms of ALS. They published their results in the journal Molecular Therapy.
“Many ALS studies are focused on preventing or delaying the onset of the disease. However, in the real world, most patients are not diagnosed until symptoms are advanced,” said graduate student Colin Lim. “Slowing progression, rather than preventing it, may have a greater impact on patients.” Lim is the co-first author of the study along with graduate students Michael Gapinske and Alexandra Brooks.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Lou Gehrig’s disease
- Gehrig's story continues to inspire worldwideon June 20, 2021 at 2:36 pm
We look to baseball for stories. Stories of heroism, of adventure, of resilience in the face of adversity. It’s why the game resonates with us -- after all, without those tales, the game is just that, ...
- 'It's a horrible disease'; Londoners walk to raise funds for ALS support and researchon June 20, 2021 at 12:26 pm
Sunday morning, Fickling and her 'Team Forget Me Not' were taking part in the Walk to End ALS in London, Ont. "It's a horrible disease," says Fickling. "It just slowly takes away your abilities to ...
- Local pharma to begin phase 2 clinical trial for Lou Gehrig’s disease therapyon June 17, 2021 at 1:45 am
The Ministry of Food and Drug Safety has granted approval for a phase 2a clinical trial of Engensis, an investigational gene therapy for treating amyotrophic lateral sclerosis, also known as Lou ...
- Links between Lou Gehrig's disease, CTE and brain injury becoming apparenton June 14, 2021 at 7:00 am
Amyotrophic lateral sclerosis (ALS) has returned to the headlines recently on a national level, with MLB celebrating its first Lou Gehrig Day earlier this month, and locally, with the news ...
- An unvarnished account of her father’s decline from Lou Gehrig’s diseaseon June 13, 2021 at 1:00 am
Here Fagan, a former ESPN columnist and commentator, and the author of the coming-out memoir “The Reappearing Act,” opens up about the burdens and rewards of caring for her father as he deteriorated ...
Go deeper with Google Headlines on:
Lou Gehrig’s disease
Go deeper with Bing News on:
- Walk to end ALSon June 20, 2021 at 4:33 pm
A 53 year-old man with Dementia raised over 16-thousand dollars for charity by taking part in the walk to end ALS. Raising the money wasn’t his only goal. Manesa Dhanabalan explains.
- ALS patient pulls all-night walk in race for better treatmentson June 20, 2021 at 3:56 pm
Held by supporters, Deane Gorsline slowly shuffled beneath the Peace Tower on Sunday, wearing a bright purple T-shirt in the race of his life. Gorsline, 32, is battling advanced ALS and chose an ...
- 'There wasn't a dry eye in the building': 9/11 firefighter with ALS enjoys daughter's wedding dayon June 20, 2021 at 8:06 am
Not even ALS could prevent a heroic New York City firefighter from sharing a special wedding day moment with his daughter.
- Column: ‘Wired to be happy,’ ALS not slowing down Naperville business owner and fatheron June 20, 2021 at 6:24 am
Despite battling a fatal progressive disease that severely limits his time and his mobility, Paul Milano is still setting goals that, just recently, included giving his daughter away at her wedding ...
- Saving Lisa from ALS: A dying patient’s ‘right to try’on June 19, 2021 at 2:52 pm
Lisa has been leading the fight for access to an investigational drug that could extend lives of patients with fatal diseases ...